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The editorial board of Aging reviews research papers published in 2009,
which they believe have or will have a significant impact on aging research.
Among many others, the topics include genes that accelerate aging or in
contrast promote longevity in model organisms, DNA damage responses
and telomeres, molecular mechanisms of life span extension by calorie
restriction and pharmacologic interventions into aging.  The emerging
message in 2009 is that aging is not random but determined by a
genetically-regulated longevity network and can be decelerated both
genetically and pharmacologically. 
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The 2009 Nobel Prize in Physiology or Medicine was 
awarded to Elizabeth Blackburn, Carol Greider and Jack 
Szostak for their contributions to our understanding of 
how the ends of eukaryotic chromosomes, telomeres, 
are maintained by a specialized reverse transcriptase, 
telomerase.  This award is the closest Nobel Prize to 
date related to aging. Of course, the major significance 
of the work relates to basic cell biology and cancer, 
rather than aging research.  In fact, whereas telomere 
shortening explains the Hayflick limit (replicative 
senescence) in human cells, it cannot explain the 
difference in longevity between mice and men.  But 
there may be other links between telomeres and aging.  
In 2009, several publications by Epel, Blackburn and 
co-workers provide a new link between telomere length 
and age-related diseases.  As published in the first issue 
of Aging, the rate of telomere shortening in peripheral 
leukocytes predicts mortality from cardiovascular 
disease in elderly men [1].  Even more intriguingly, 
pessimism correlates with short leukocyte telomeres and 
elevated interleukin (IL)-6 in post-menopausal women 
[2].  The cause-and-effect relationship between telomere 
length and these physiological endpoints is unknown, but 
several non-mutually exclusive explanations can be 
proposed.  Rapid telomere shortening may indicate a 
cellular hyper-activation, hyper-proliferation and/or 
hyper-secretory phenotypes often associated with cellular 
senescence, stem cell exhaustion and diseases of aging.   
 
In agreement with these possibilities, telomere length was 
shown to regulate the expression of interferon-stimulated 
gene 15 (ISG15).  Short-telomeres up-regulated ISG15 
independent of DNA damage signaling.  This finding 
demonstrated for the first time that an endogenous human 
gene can be regulated by telomere length prior to the 
onset of telomere dysfunction and DNA damage signals.  
It was suggested that the upregulation of ISG15 by 
telomere shortening may contribute to the chronic 
inflammation associated with human aging [3].  Pertinent 
to this idea, also in 2009, the secretion of inflammatory 
cytokines such as IL-6 and IL-8 by senescent cells, 
whether made senescent by dysfunctional telomeres or 
DNA damage, was shown to be suppressed by two 
micro-RNAs (miR-146a and 146b) [4]. It was proposed 
that these micro-RNAs modulate inflammatory responses 
by affecting signal transduction pathways that contribute 
to a larger senescence associated secretory phenotype.  It 
will be of interest to know whether miR-146a/b also 
suppresses ISG15 expression, and if this effect is 
influenced by telomere status. 
 
It was also demonstrated that dysfunction of a telomere-
binding protein is sufficient to produce severe telomeric 
damage in the absence of telomere shortening, resulting 
in premature tissue degeneration and development of 
neoplastic lesions [5]. New insight has been gained in 
the understanding of how telomeres are maintained and 
how the processes of DNA repair occur in telomeres.  
For example, it appears that the guardians of the 
genome, the RecQ helicases, actively participate in this 
repair process [6]. 
 
Damaged telomeres were also found to be the major 
factor contributing to the wide variability in the 
amount of DNA damage signaling in human tumor cell 
lines, findings that may help clarify the relative 
contributions of non-telomeric DNA double-strand 
breaks and damaged telomeres to levels of genomic 
instability [7]. 
 
DNA damage response and aging 
 
In 2009, it was demonstrated that the persistent (but not 
transient) DNA damage response (DDR) associated 
with senescent cells is essential for their ability to 
express and secrete inflammatory cytokines [8]. Cell 
surface-bound IL-1alpha is essential for the senescence-
associated secretion of IL-6 and IL-8, 2 proinflam-
matory cytokines, reinforcing the senescence phenotype 
[9]. 
 
Both the initiation and maintenance of cytokine 
secretion required the DDR proteins ATM, NBS1 and 
CHK2, but not p53.  ATM was also essential for IL-6 
secretion during oncogene-induced senescence and by 
damaged cells that bypass senescence.  It was proposed 
that this activity of the DDR allows senescent cells to 
communicate their compromised state to the 
surrounding tissue [8].  In addition, a DDR may occur 
in senescent cells even in the absence of detectable 
DNA damage [10].  This pseudo-DDR is a marker of 
cellular hyperactivation and is inhibited by rapamycin 
[10], a clinically approved drug that decelerates cellular 
senescence [11]. Thus, persistent DDR signaling, 
regardless of DNA damage, may be a part of the 
senescent phenotype.  
 
It was shown that longevity extension mutations in the 
yeast SCH9, the yeast homolog of the conserved pro-
aging gene S6K (Ribosomal Protein S6 Kinase), caused 
a major reduction in age-dependent DNA damage by 
lowering the activity of error-prone DNA repair genes 
[12].  
 
Also, age-dependent deterioration of nuclear pore 
complexes causes an increase in nuclear permeability 
and the leaking of cytoplasmic proteins into the nucleus 
in postmitotic cells [13]. 
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Stress-responding factors which regulate transcription 
can influence longetivity.  In 2009, Westerheide et al 
demonstrated that stress-induced regulation of heat 
shock factor 1 (HSF-1) by the deacetylase SIRT1 
(sirtuin 1) may play a role in the regulation of life span 
[14].  Defining the targets of sirtuins may help to 
understand the importance of transcriptional regulation 
in age-related diseases.  
  
An intriguing possibility is that the response of the cells 
to certain types of DNA damage (e.g. DNA breaks) 
results in epigenetic changes that alter gene expression 
[15].  These changes do occur in mammals and it will 
be interesting to test whether these epigenetic changes 
in response to DNA damage are associated with, or can 
actually cause aging. 
 
Mitochondria, oxidative stress and aging 
 
 On the other hand, the free radical theory, which posits 
that aging is caused by an accumulation of oxidative 
damage, was critically questioned in 2009.  First, 
overexpression of major antioxidant enzymes, which 
decrease free radicals, did not extend the lifespan of 
mice [16].  Second, deletion of mitochondrial 
superoxide dismutase (Sod-2) extended life span in 
Caenorhabditis elegans [17].  Third, life span extension 
by dietary restriction was not linked to protection 
against somatic DNA damage in Drosophila 
melanogaster [18].  Fourth, Sod-2 haploinsufficiency 
did not accelerate murine aging, even in mice with 
dysfunctional telomeres [19]. In addition it was 
demonstrated that the reduced energy metabolism and 
the increased oxidative stress in the mitochondria of 
young Mclk1+/- mice results in an almost complete 
protection from the age-dependent loss of mitochondrial 
function. Moreover, this altered mitochondrial condition 
is linked to a significant attenuation of the rate of 
development of oxidative biomarkers of aging. Thus, 
this study indicates that mitochondrial oxidative stress 
is not causal to aging [20]. It was reported that RNAi of 
five genes encoding components of mitochondrial 
respiratory complexes I, III, IV, and V leads to 
increased life span in flies. Long-lived flies with 
reduced expression of electron transport chain (ETC) 
genes do not consistently show reduced assembly of 
respiratory complexes or reduced ATP levels. In 
addition, extended longevity is not consistently 
correlated with increased resistance to the free-radical 
generator paraquat [21]. 
 
These results are in agreement with previous papers 
showing that antioxidants overexpression causes minor 
effects in life span extension in yeast, flies, and mice 
compared to those caused by mutations in signal 
transduction genes. It is likely that increase protection 
against superoxide must be accompanied by a number 
of other changes to be effective in life span extension. 
For instance, LON, a AAA protease located in the mito-
chondrial matrix, increases stress tolerance, 
mitochondrial oxygen consumption, while decreasing 
oxidative damage of proteins in the fungal aging model 
Podospora anserine [22]. In the same model organism, 
deletion of a gene encoding a O-methyltransferase, 
which decrease levels of reactive oxygen species, leads 
to a decreased lifespan [23].  
 
Calorie restriction (CR) 
 
Caloric restriction (CR) without malnutrition delays 
aging and extends life span in diverse species; however, 
its effect in primates had not been clearly established.  
In 2009, a 20-year longitudinal study of adult-onset CR 
in rhesus monkeys demonstrated that moderate CR 
lowered the incidence of aging-related deaths.  At the 
time point reported, 50% of control animals had 
survived, compared with 80% of CR animals.  CR 
delayed the onset of several age-associated pathologies 
such as diabetes, cancer, cardiovascular disease and 
brain atrophy [24]. The CR trial in primates raised hope 
that CR might be effective in humans.   
 
In 2009, numerous studies continued to establish links 
between caloric restriction (CR) and longevity signaling 
pathways, including Sir2 (sirtuin) and p53 in D. 
melanogaster [25] and the E3 ubiquitin ligase WWP-1 
in C. elegans [26] as well as upstream and downstream 
components of the TOR (Target of Rapamycin) 
pathway: RHEB-1 in C. elegans [27], Tor1 and Sch9 (a 
homolog of the mammalian kinases Akt and S6K) in 
yeast [28], and 4E-BP (Eukaryotic Translation Initiation 
Factor 4E Binding Protein) in Drosophila [29]. It was 
shown that glucose shortens the life span of C. elegans 
by downregulating DAF-16/FOXO activity and 
aquaporin gene expression [30]. In addition, the HIF 
(hypoxia inducible factor) pathway was implicated in 
aging and longevity in C. elegans [31, 32]. The different 
results of two studies have been in general reconciled 
[33]. In 2009, it has also been shown that in C. elegans 
CR is mediated by a network of independent, but 
overlapping pathways [34], suggesting a ‘CR network’. 
Notably, neuronal SIRT1 regulated endocrine and 
behavioral responses to CR [35].  
 
It has been shown that disruption of growth hormone 
receptor (GHR) prevents calorie restriction from 
improving insulin action and longevity [36]. In normal 
mice, CR increased insulin sensitivity in liver and 
muscle. In GHRKO mice, intrinsic insulin-sensitivity 
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phosphorylation of IRS-1 (Insulin receptor substrate 1) 
in muscle. CR failed to further increase insulin 
signaling (insulin sensitivity) in GHRKO mice as 
compared to normal mice, likely explaining the absence 
of CR effects on longevity in these long-lived mice 
[36].  
 
Finally, it was tested whether reallocation of nutrients 
from reproduction to somatic maintenance could 
explain the life extending effect of CR. If this were the 
case, long life under dietary restriction and high 
fecundity (reproduction) under full feeding would be 
mutually exclusive. Adding methionine alone to the 
dietary restriction condition was necessary and 
sufficient to increase fecundity as much as did full 
feeding, but without reducing lifespan. Reallocation of 
nutrients therefore does not explain the responses to 
dietary restriction. In contrast, reduced activity of the 
insulin/insulin-like growth factor signaling protected 




The ultimate goal of biomedical research is the 
development of therapeutic drugs. As shown previously, 
activation of mTOR (mammalian Target of Rapamycin) 
is required for acquiring senescent phenotype in p21-
arrested human cells, whereas deactivation of mTOR 
converts senescence into quiescence. In 2009, it was 
further demonstrated that the inhibitor of mTOR 
rapamycin decelerated cellular senescence of p21-
arrested human and mouse cells [11]. Similarly, 
inhibitors of PI-3K and MEK, LY-294002 and U0126, 
deactivated mTOR and suppressed cellular senescence 
(converting it into quiescence) [38], defining direct and 
indirect mTOR inhibitors as aging-suppressants or gero-
suppressants. 
 
The most striking event of the year was the 
demonstration that rapamycin, administrated to middle-
aged (600 day old) mice, significantly extended their 
life span [39]. The effect was seen at three independent 
test sites in genetically heterogeneous mice, chosen to 
avoid genotype-specific effects on disease susceptibility 
[39]. Rapamycin also prolonged the life of 22-month 
old mice [40]. [Note: publications by Bjedov et al (Cell 
Metab 2010 Jan) and by Moskalev and Shaposhnikov 
(coming in print 2010) that rapamycin extends life span 
in Drosophila will be reviewed next year].  
 
It was shown that clioquinol, a metal chelator that has 
beneficial effects in several models of neuro-
degenerative diseases, inhibits the activity of the 
mitochondrial enzyme CLK-1 in mammalian cells. 
Clioquinol-treated nematodes and mice presented a 
variety of phenotypes produced by mutational reduction 
of CLK-1. Given that reduction of CLK-1 slows down 
aging in these organisms, these results suggest that 
clioquinol (by inhibiting CLK-1) may slow down the 
aging process [41]. 
 
Finally, as a follow-up of the work on the anti-aging 
effects of mitochondria-targeted antioxidant SkQ1 [42], 
it was demonstrated that Sk inhibits age-dependent 
involution of the thymus in normal and senescence-
prone rats [43]. 
 
Stem cells and aging 
 
In 2009, several lines of evidence suggested that 
overactivation of signaling pathways might cause 
exhaustion of stem cells and that vice versa ‘longevity 
genes’ could prevent stem cell exhaustion.  Thus, 
mTOR mediated Wnt-induced epidermal stem cell 
exhaustion and aging phenotypes in skin [44].  Further, 
hyper-activation of mTORC1 caused hyper-
proliferation and subsequent exhaustion of 
hematopoietic stem cells.  Pharmacological approaches 
showed that PTEN, TSC1 and PML regulate 
hematopoietic stem cell (HSC) maintenance through 
mTORC1 [45].  In addition, FOXO transcription factors 
were found to be necessary for adult neural stem cell 
homeostasis  [46, 47]. Importantly, stem cell aging 
could be suppressed pharmacologically [40, 44]. The 
PI3K-AKT-FoxO pathway is integral to lifespan 
regulation in lower organisms  plays a prominent role in 
neural stem/progenitor cell (NSC) proliferation and 
renewal. FoxO-deficient mice show initial increased 
brain size and proliferation of neural progenitor cells 
during early postnatal life, followed by precocious 
significant decline in the NSC pool and accompanying 
neurogenesis in adult brains [46]. 
 
In addition, functions of aging organs can be 
rejuvenated by young supporting stem cells.  As 
published in the first issue of Aging, once-monthly 
infusions of bone marrow (BM)-derived cells from 
young adult female mice sustained the fertility of aging 
females long past their time of normal reproductive 
failure [48].  The fertility-promoting effects were 
observed regardless of whether the infusions were 
initiated in young adult or middle-aged females, and 
were specific for bone marrow harvested from female 
donors.  This “rejuvenation” did not depend on the 
development of mature eggs from germline cells in the 
donor marrow, but from host germline cells sustained 
by the infusions [48, 49]. In fact, very recent studies 
showed that aged mouse ovaries lacking oocytes retain 
a rare population of germline stem cells that, when 
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able to generate immature oocytes contained within 
follicles [49]. Thus, reproductive failure with age may 
be due, at least in part, to deterioration of somatic 
microenvironments (niches) that support stem cell 
function.   
  
Nuclear reprogramming and senescence 
 
Much interest has also been devoted in the past year to 
nuclear reprogramming of differentiated cells into 
induced pluripotent stem (iPS) cells by using defined 
factors. Understanding which factors facilitate the 
reprogramming process is thought to give clues to the 
process of carcinogenesis. Inversely, nuclear re-
programming could be also envisioned as a 
“rejuvenation process”. In this regard, p53 and p16
INK4a 
tumor suppressor proteins were shown to be important 
in limiting reprogramming [50-55].  Activation of p53 
was suggested to be more important in murine cells, 
whereas activation of p16
INK4a appeared the 
predominant barrier in human cells [50].   
 
Of particular importance to the field of regenerative 
medicine, which will need patient-specific stem cells 
derived from older patients, is reprogramming 
efficiency in fibroblasts from aged humans versus 
young humans.  There is an age-associated decline in 
reprogramming efficiency, which is largely reversed by 
inactivation of the p16
INK4a tumors suppressor gene, 
whose expression is increased markedly with aging in 
several human and murine tissues [50, 55].  Along these 
lines, it was shown that the increased expression of 
p16INK4a with aging could be measured on human 
peripheral blood samples, and that an individual’s 
p16INK4a expression was a good biomarker of their 
“molecular age” [56]. The same group also provided 
further understanding of the observed linkage of SNPs 
near the CDKN2a/b locus (which encodes the p16
INK4a, 
p15
INK4b and ARF tumor suppressors) with human 
atherosclerotic disease [57].  Expression of CDKN2a/b 
transcripts is decreased in individuals harboring the risk 
alleles, suggesting that atherosclerotic disease may 
result from aberrant, unrestrained proliferation. In this 
regard, studies on mice overexposing the CDKN2a/b 
locus were found to have delayed aging and extended 
longevity [58]. 
 
Genetics of aging 
 
In 2009, numerous publications extended our 
knowledge on the role of sirtuins [35], TOR signaling 
[59, 60], and the stress response factors HSF-1 and 
DAF-16 [61] in aging.  Of particular importance, it was 
shown that deletion of the gene encoding Ribosomal 
Protein S6 Kinase 1 (S6K1) and disruption of PKA 
extend the life span of mice [62, 63], whereas the gene 
encoding Eukaryotic Translation Initiation Factor 4E 
Binding Protein (4E-BP) was shown to be essential for 
life span extension by CR in Drosophila [29].   
Moreover, 4E-BP was shown to act downstream of 
TOR to modulate cardiac aging in Drosophila [64].   
Finally, SIRT6 was shown to play a critical role in 
DNA double-strand break repair [65]. 
 
In 2009, Kenyon and co-workers further uncovered 
mechanisms of their previous observations made in 
1999 (Hsin and Kenyon, Nature, 1999, 399:362-6) that 
in C elegans and Drosophila the aging of the soma is 
influenced by the germline: namely, when germline-
stem cells are removed, aging slows and lifespan is 
increased. In 2009, it was published that a predicted 
transcription elongation factor, TCER-1, plays a key 
role in this process [66]. When the germ cells are 
removed, the levels of TCER-1 rise in somatic tissues. 
This increase is sufficient to trigger key downstream 
events, as overexpression of tcer-1 extends the lifespan 
of normal animals that have an intact reproductive 
system. Intriguingly, TCER-1 specifically links the 
activity of a broadly deployed transcription factor, 
DAF-16/FOXO, to longevity signals from reproductive 
tissues [66]. In mice, Foxo1 integrates insulin signaling 
with mitochondrial function, and inhibition of Foxo1 
can improve hepatic metabolism during insulin 
resistance and the metabolic syndrome [67]. 
 
A prior  work by Willcox et al (PNAS 2008, 105: 
13987) showed that genetic variation within the 
FOXO3A gene was strongly associated with human 
longevity. Long-lived men also presented several 
additional phenotypes linked to healthy aging, including 
lower prevalence of cancer and cardiovascular disease, 
and high physical and cognitive function. Long-lived 
men also exhibited greater insulin sensitivity associated 
with homozygosity for the FOXO3A GG genotype. In 
2009, confirming the Willcox observation, the flurry of 
papers showed the association between SNPs in the 
FoxO3A gene and extreme longevity in Japanese, 
German, American, Italian, and Chinese populations 
[68-71].  
 
 There were intriguing publications on the complex role 
of p53 in longevity.  In Drosophila melanogaster, p53 
exerted developmental stage-specific and sex-specific 
effects on adult life span, indicative of sexual 
antagonistic pleiotropy [72, 73].  Further, an association 
between single nucleotide polymorphisms (SNPs) in 
p53 pathway genes and human fertility suggested that 
p53 regulates the efficiency of human reproduction.   
These results provide a plausible explanation for 
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pathway, and suggest that such alleles are a good 
example of antagonistic pleiotropy [74].   
 
Interestingly, SNPs in the p21 gene correlated with 
longevity in an Italian population [75]. Several papers 
have highlighted an important role of p53 in tissue 
fitness through its impact in preventing mobilization of 
stem cells harboring persistent DNA damage (ie, 
dysfunctional telomeres) [76, 77]. However, the 
phenotypic outcome was tissue and context specific. In 
mouse epidermis deletion of p53 rescued organ 
maintenance and body fitness of neborn mice with 
dysfunctional telomeres [76]. In contrast, p53 deletion 
in the intestinal epithelium accelerated tissue 
dystruction and shortened the lifespan of aging telomere 
dysfunctional mice [77]. The latter phenotype was 
associated with aberrant survival chromosomal instable 
stem cell clones leading to abnormal differentiation and 
p53-independent apoptosis. The limitation of the 
survival of chromosomal instable stem cells is likely to 
represent a key step in the known role of p53 as a tumor 
suppressor. Also it was shown that the p53 family 
member, TAp63, is essential for maintenance of 
epidermal and dermal precursors and that, in its 
absence, these precursors senesce and skin ages 
prematurely [78]. 
 
Model systems continue to be instrumental in 
understanding the genetics of longevity.  The WRN gene 
defective in the premature aging disorder Werner 
syndrome encodes a protein with both helicase and 
exonuclease activities [79].  To dissect its genetic 
functions, human WRN was tested for its ability to 
rescue sgs1-related phenotypes.  WRN was shown to 
genetically interact with topoisomerase 3 and restore the 
slow growth phenotype of sgs1 top3.  WRN helicase but 
not exonuclease activity was genetically required for 
restoration of top3 growth phenotype, demonstrating 
separation of function of WRN catalytic activities.  In a 
top3 mutant background, DNA unwinding by WRN 
helicase may be deleterious to cell growth and genome 
homeostasis [80].   
 
In 2009, a few studies delved into the genetics of the 
insulin-producing pancreatic beta-cell aging in humans 
and mice [81-83].  A loss of beta-cell replication with 
aging is a contributor to age-related increase in the 
incidence of type II diabetes.  Prior work had shown 
that p16
INK4a tumor suppressor causes an age-dependent 
decline in beta-cell replication.  In 2009, it was reported 
that loss of Polycomb (PcG) repression of p16INK4a 
mediated by the EZH2 histone methytransferase 
occurred with aging in humans and mice [82].  In mice, 
somatic deletion of EZH2 led to loss of beta-cell 
replication and diabetes, and these effects could be 
rescued by concomitant deletion of  p16
INK4a and Arf. 
   
This work linked alterations of chromatin architecture 
with aging to expression of anti-proliferative molecules.  
Bhushan and colleagues also reported a similar 
regulation of p16
INK4a expression with aging by the 
Bmi-1 PcG protein, which functions in concert with 
EZH2 to repress p16
INK4a expression [81]. Lastly, it was 
shown that p38MAPK activates p16I
NK4a with aging in 
beta-cells, suggesting a possible pharmacologic 




In 2009, the simple dogma that autophagy is always 
associated with or causes senescence was challenged. 
Although autophagy remains a crucial anti-aging 
mechanism, the relationship is likely to be complex.   
Thus, autophagy was shown to be activated during 
cellular senescence, and activation correlated with 
negative feedback in the PI3K-mTOR pathway. A 
subset of autophagy-related genes was up-regulated 
during senescence: overexpression of one gene, ULK3, 
induced autophagy and senescence.  Furthermore, 
inhibition of autophagy delayed the senescence 
phenotype, including senescence-associated secretion.   
These data suggest that autophagy, and its consequent 
protein turnover, may mediate acquisition of the 
senescence phenotype [84]. Inhibition of autophagy in 
adult Drosophila [85] or C. elegans [86] was found not 
to affect longevity, however autophagy was required for 
the increased life span caused by several pharmocologic 
and genetic manipulations in yeast, Drosophila and C. 
elegans [87-90], suggesting that autophagy may be 
limiting for life span under some conditions but not 
others.  Interestingly, resveratrol-mediated inhibition of 
mammalian S6 kinase by resveratrol suppressed 
autophagy [91].  In 2009, several reports further 
demonstrated that the TOR signaling pathway targets 
the Atg1/Atg13 protein kinase complex to control 
autophagy [92-94]. Furthermore, TOR-mediated 
autophagy regulates cell death in Drosophila 
neurodegenerative disease [95]. 
 
The natural polyanion spermidine can extend the 
chronological and replicative life span in yeast and 
increase the median and maximal longevity of fruit flies 
and nematodes (C. elegans). Spermidine was found to 
act as a potent inducer of autophagy in all species 
tested, including yeast, Drosophila, C. elegans [96].   
The antiaging effect of spermidine was abolished by the 
deletion or depletion of essential autophagy genes in 
yeast,  Drosophila and C. elegans [96]. In mice, a 
dietary supplementation with polyanions (including 
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although the dependency of this phenomenon on 
autophagy has not been addressed yet. Spermidine 
likewise induces autophagy and longevity through its 
capacity to inhibit histone acetylases in yeast cells [96]. 
 
Sirtuin-1 and that of its C. elegans orthologue induce 
autophagy in human and nematode cells. Sirtuin-1 is 
also required for the induction of autophagy by its 
allosteric activator resveratrol (both in human cells and 
nematodes), culture in nutrient-free media (in human 
cells) and caloric restriction (in nematodes). In C. 
elegans, it was found that activation of Sirtuin-1 
extended longevity in an autophagy-dependent fashion. 
Thus, the knockdown of the essential autophagy gene 
Beclin1/ATG6 abolished life span extension by Sirtuin-
1 activation [87]. These results underscore the 
contribution autophagy to the regulation of longevity by 
pharmacological agents [98]. 
 
Post-transcriptional gene regulation and aging 
  
In fact, 2009 saw an escalation in interest in 
microRNAs and other non-coding RNAs implicated in 
aging and replicative senescence.  A prominent example 
of this regulation came studies of the mitogen-activated 
protein kinase (MAPK) signaling component MKK4 
(MAPK kinase kinase 4).  MKK4 levels were elevated 
in aging tissues and in senescent cells thanks to 
reductions in the abundance of four microRNAs (miR-
15b, miR-24, miR-25, and miR-141) that interacted 
with the 5’- and 3’-untranslated regions of the MKK4 
mRNA and repressed its translation [99].   
 
The other major class of post-transcriptional regulatory 
factors, RNA-binding proteins (RBPs), were also the 
focus of important age-related studies in 2009.  Several 
RBPs that affect the turnover and translation of proteins 
implicated in proliferation, survival, inflammation, 
neurodegeneration, and cancer (HuR, AUF1, TIA-1, 
TTP) displayed elevated abundance in a broad array of 
human tissues and in all ages, suggesting that their 
influence extends throughout the human life span [100].  
The RBP TTP (tristetraprolin) attracted especial 
attention because it triggered replicative senescence 
[101]; in keeping with the tumor-suppressive influence 
of replicative senescence, TTP was found to be 




There is growing evidence for a link between circadian 
rhythm,  signal-transduction genes, metabolism, cancer 
and aging [103, 104].  The circadian clock gene period 
extended the health span of aging in Drosophila 
melanogaster [105].  Further, circadian control of the 
NAD+ salvage pathway by CLOCK-SIRT1 was 
demonstrated [106].  Intriguingly, light was found to 
activate MAPK (mitogen activated pathway kinase) in 
zebrafish cells, and this light-dependent activation 
controlled DNA repair [107]. In rats, circadian 
disruption induced by light-at-night accelerates aging 
and promotes tumorigenesis in rats [108]. In mice, it 
was reported that N-acetyl-L-cysteine (NAC), an 
antioxidant, ameliorated symptoms of premature aging 
associated with the deficiency of the circadian protein 
BMAL1 [109]. 
 
Cancer and aging 
 
CR is known to slow aging and delay cancer.  In 2009, 
it was reported that fasting abrogates side effects caused 
by chemotherapy in cancer patients.  Importantly, for 
those patients in whom cancer progression could be 
assessed, fasting did not prevent chemotherapy-induced 
reduction of tumor volume or tumor markers [110].   
The link between aging and cancer via p53 was shown 
to be complex in 2009.  Thus, the ability of p53 to act as 
a defense against tumor progression was shown to be 
age-dependent [111].  Further, Levine and co-workers 
previously showed that p53 activity declines with age, 
and a recent study showed that p53 transcriptional 
activity is reduced in senescent cells [112]. 
Interestingly, SIRT1 knockout mice, which do not live 
longer when calorically restricted, were found to have 
normal rates of skin cancer but the ability of resveratrol, 
a SIRT1 activator, to protect the mice was greatly 
reduced [113], indicating that the anti-tumor activity of 
resveratrol is mediated at least in part by SIRT1. 
 
Reduced incidence and delayed occurrence of fatal 
neoplastic diseases in growth hormone receptor/binding 
protein knockout mice.  These changes of fatal 
neoplasms are similar to the effects observed with 
calorie restriction and therefore could possibly be a 
major contributing factor to the extended life span 
observed in the GHR/BP KO mice. [114]  
 
Overall, 2009 was an exciting year for increasing our 
understanding of aging and its relationship to age-
related disease, and developing promising strategies and 
candidates for pharmacological interventions into the 
aging process. Several approaches in combination with 
drugs and diet may slow aging, although not making it 
negligible [115]. 
  
ACKNOWLEDGMENTS AND ANNOUNCEMENTS 
 
We apologize to the authors whose important 
publications were not discussed due to space limitations 
   
www.impactaging.com                   117                                         AGING, March 2010, Vol.2 No.3or were simply overlooked. Here we referenced only 
papers published in the 2009 calendar year. That was 
not an easy task given that most of publications are the 
continuation of or based on previous research. We 
expect to make this a tradition to publish ‘the year 
overview’ every year. The next year, the task will be 
easier, given that “Aging in 2010” will be the 
continuation of “Aging in 2009”.  
 
Please e-mail your reprints to us in December 2010 
(editors@impactaging.com) or, even better, please 







mortality  from  cardiovascular  disease  in  elderly  men.  Aging  
2009, 1: 81‐88. 
2.  O'Donovan  A,  Lin  J,  Dhabhar  FS,  Wolkowitz  O,  Tillie  JM, 
Blackburn  E,  Epel  E.  Pessimism  correlates  with  leukocyte 
telomere  shortness  and  elevated  interleukin‐6  in  post‐
menopausal women. Brain Behav Immun  2009, 23: 446‐449. 
3.  Lou  Z,  Wei  J,  Riethman  H,  Baur  JA,  Voglauer  R,  Shay  JW, 
Wright  WE.  Telomere  length  regulates  ISG15  expression  in 
human cells. Aging 2009, 1: 608‐621. 
4. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Orjalo AV, Rodier 





Increased  telomere  fragility  and  fusions  resulting  from  TRF1 
deficiency  lead  to  degenerative  pathologies  and  increased 
cancer in mice. Genes Dev  2009, 23: 2060‐2075. 
6. Ghosh A, Rossi ML, Aulds J, Croteau D, Bohr VA. Telomeric D‐
loops  containing  8‐oxo‐2'‐deoxyguanosine  are  preferred 
substrates for Werner and Bloom syndrome helicases and are 
bound by POT1. J Biol Chem  2009, 284: 31074‐31084. 
7.  Nakamura  AJ,  Redon  CE,  Bonner  WM,  Sedelnikova  OA. 







surface‐bound  IL‐1alpha  is  an  upstream  regulator  of  the 
senescence‐associated  IL‐6/IL‐8  cytokine  network.  Proc  Natl 
Acad Sci U S A  2009, 106: 17031‐17036. 
10.  Pospelova  TV,  Demidenk  ZN,  Bukreeva  EI,  Pospelov  VA, 
Gudkov AV, Blagosklonny MV. Pseudo‐DNA damage response in 
senescent cells. Cell Cycle  2009, 8: 4112‐4118. 




MF,  Longo  VD.  Oncogene  homologue  Sch9  promotes  age‐
dependent  mutations  by  a  superoxide  and  Rev1/Polzeta‐
dependent mechanism. J Cell Biol  2009, 186: 509‐523. 
13.  D'Angelo  MA,  Raices  M,  Panowski  SH,  Hetzer  MW.  Age‐
dependent  deterioration  of  nuclear  pore  complexes  causes  a 
loss of nuclear integrity in postmitotic cells. Cell  2009, 136: 284‐
295. 

















not  accelerate  aging  of  telomere  dysfunctional  mice.  Aging  
2009, 1: 303‐315. 
20. Lapointe J, Stepanyan Z, Bigras E, Hekimi S. Reversal of the 
mitochondrial  phenotype  and  slow  development  of  oxidative 






22.  Luce  K,Osiewacz  HD.  Increasing  organismal  healthspan  by 
enhancing  mitochondrial  protein  quality  control.  Nat  Cell  Biol  
2009, 11: 852‐858. 
23.  Kunstmann  B,Osiewacz  HD.  The  S‐adenosylmethionine 
dependent O‐methyltransferase PaMTH1: a longevity assurance 
factor  protecting  Podospora  anserina  against  oxidative  stress. 
Aging  2009, 1: 328‐334. 
24.  Colman  RJ,  Anderson  RM,  Johnson  SC,  Kastman  EK, 
Kosmatka KJ, Beasley TM, Allison DB, Cruzen C, Simmons HA, 

















TA,  Benzer  S,  Kapahi  P.  4E‐BP  extends  lifespan  upon  dietary 
   
www.impactaging.com                   118                                         AGING, March 2010, Vol.2 No.3restriction  by  enhancing  mitochondrial  activity  in  Drosophila. 
Cell  2009, 139: 149‐160. 
30. Lee SJ, Murphy CT, Kenyon C. Glucose shortens the life span 
of  C.  elegans  by  downregulating  DAF‐16/FOXO  activity  and 
aquaporin gene expression. Cell Metab  2009, 10: 379‐391. 
31.  Chen  D,  Thomas  EL,  Kapahi  P.  HIF‐1  modulates  dietary 








34.  Greer  EL,Brunet  A.  Different  dietary  restriction  regimens 
extend  lifespan  by  both  independent  and  overlapping  genetic 
pathways in C. elegans. Aging Cell  2009, 8: 113‐127. 
35. Cohen DE, Supinski AM, Bonkowski MS, Donmez G, Guarente 
LP.  Neuronal  SIRT1  regulates  endocrine  and  behavioral 








explains  extension  of  lifespan  by  dietary  restriction  in 
Drosophila. Nature  2009, 462: 1061‐1064. 
38.  Demidenko  ZN,  Shtutman  M,  Blagosklonny  MV. 












Hihi  A,  Hayes  S,  McBride  K,  Hekimi  S.  The  anti‐
neurodegeneration drug clioquinol inhibits the aging‐associated 
protein CLK‐1. J Biol Chem  2009, 284: 314‐323. 
42.  Skulachev  VP,  Anisimov  VN,  Antonenko  YN,  Bakeeva  LE, 
Chernyak  BV,  Erichev  VP,  Filenko  OF,  Kalinina  NI,  Kapelko  VI, 
Kolosova  NG,  Kopnin  BP,  Korshunova  GA,  Lichinitser  MR, 
Obukhova LA, Pasyukova EG, Pisarenko OI, Roginsky VA, Ruuge 
EK, Senin, II, Severina, II, Skulachev MV, Spivak IM, Tashlitsky VN, 
Tkachuk  VA,  Vyssokikh  MY,  Yaguzhinsky  LS,  Zorov  DB.  An 
attempt  to  prevent  senescence:  a  mitochondrial  approach. 
Biochim Biophys Acta  2009, 1787: 437‐461. 














47.  Renault  VM,  Rafalski  VA,  Morgan  AA,  Salih  DA,  Brett  JO, 
Webb AE, Villeda SA, Thekkat PU, Guillerey C, Denko NC, Palmer 














Raya  A,  Wahl  GM,  Belmonte  JC.  Linking  the  p53  tumour 
suppressor  pathway  to  somatic  cell  reprogramming.  Nature  
2009, 460: 1140‐1144. 
52. Utikal J, Polo JM, Stadtfeld M, Maherali N, Kulalert W, Walsh 
RM,  Khalil  A,  Rheinwald  JG,  Hochedlinger  K.  Immortalization 
eliminates a roadblock during cellular reprogramming into iPS 
cells. Nature  2009, 460: 1145‐1148. 
















57.  Liu  Y,  Sanoff  HK,  Cho  H,  Burd  CE,  Torrice  C,  Mohlke  KL, 






59.  Pan  Y,  Shadel  GS.  Extension  of  chronological  life  span  by 
reduced TOR signaling requires down‐regulation of Sch9p and 
involves  increased  mitochondrial  OXPHOS  complex  density. 
Aging  2009, 1: 131‐145. 




www.impactaging.com                   119                                         AGING, March 2010, Vol.2 No.361. Ben‐Zvi A, Miller EA, Morimoto RI. Collapse of proteostasis 
represents an early molecular event in Caenorhabditis elegans 
aging. Proc Natl Acad Sci U S A.  2009,  
62.  Selman  C,  Tullet  JM,  Wieser  D,  Irvine  E,  Lingard  SJ, 
Choudhury AI, Claret M, Al‐Qassab H, Carmignac D, Ramadani F, 










downstream  of  both  dTOR  and  dFoxo  to  modulate  cardiac 
functional aging in Drosophila. Aging Cell  2009, 8: 542‐552. 
65.  McCord  RA,  Michishita  E,  Hong  T,  Berber  E,  Boxer  LD, 
Kusumoto R, Guan S, Shi X, Gozani O, Burlingame AL, Bohr VA, 
Chua  KF.  SIRT6  stabilizes  DNA‐dependent  Protein  Kinase  at 
chromatin for DNA double‐strand break repair. Aging 2009, 1: 
109‐121. 
66.  Ghazi  A,  Henis‐Korenblit  S,  Kenyon  C.  A  transcription 
elongation factor that links signals from the reproductive system 













G,  Barzilai  N,  Cummings  SR,  Browner  WS,  Kwok  PY,  Ziv  E. 
Association  of  common  genetic  variation  in  the  insulin/IGF1 
signaling  pathway  with  human  longevity.  Aging  Cell  2009,  8: 
460‐472. 
70.  Anselmi  CV,  Malovini  A,  Roncarati  R,  Novelli  V,  Villa  F, 









developmental  stage‐specific  and  sex‐specific  effects  on  adult 












76.  Flores  I,  Blasco  MA.  A  p53‐dependent  response  limits 















80.  Aggarwal  M,Brosh  RM.  WRN  helicase  defective  in  the 
premature aging disorder Werner syndrome genetically interacts 
with  topoisomerase  3  and  restores  the  top3  slow  growth 
phenotype of sgs1 top3. Aging 2009, 1: 219‐233. 
81.  Dhawan  S,  Tschen  SI,  Bhushan  A.  Bmi‐1  regulates  the 
Ink4a/Arf  locus  to  control  pancreatic  beta‐cell  proliferation. 
Genes Dev  2009, 23: 906‐911. 
82. Chen H, Gu X, Su IH, Bottino R, Contreras JL, Tarakhovsky A, 
Kim  SK.  Polycomb  protein  Ezh2  regulates  pancreatic  beta‐cell 
Ink4a/Arf  expression  and  regeneration  in  diabetes  mellitus. 
Genes Dev  2009, 23: 975‐985. 
83. Wong ES, Le Guezennec X, Demidov ON, Marshall NT, Wang 
ST,  Krishnamurthy  J,  Sharpless  NE,  Dunn  NR,  Bulavin  DV. 
p38MAPK  controls  expression  of  multiple  cell  cycle  inhibitors 
and  islet  proliferation  with  advancing  age.  Dev  Cell  2009,  17: 
142‐149. 
84. Young AR, Narita M, Ferreira M, Kirschner K, Sadaie M, Darot 
JF,  Tavaré  S,  Arakawa  S,  Shimizu  S,  Watt  FM,  Narita  M. 
Autophagy  mediates  the  mitotic  senescence  transition.  Genes 
Dev.  2009, 23:798‐803 
85. Ren C, Finkel SE, Tower J. Conditional inhibition of autophagy 





87.  Morselli  E,  Galluzzi  L,  Kepp  O,  Criollo  A,  Maiuri  MC, 
Tavernarakis  N,  Madeo  F,  Kroemer  G.  Autophagy  mediates 































Weiskopf  D,  Laun  P,  Heeren  G,  Breitenbach  M,  Grubeck‐
Loebenstein B, Herker E, Fahrenkrog B, Frohlich KU, Sinner F, 
Tavernarakis  N,  Minois  N,  Kroemer  G,  Madeo  F.  Induction  of 














M.  Tissue‐  and  age‐dependent  expression  of  RNA‐binding 
proteins  that  influence  mRNA  turnover  and  translation.  Aging  
2009, 1: 681‐698. 
101.  Sanduja  S,  Kaza  V,  Dixon  DA.  The  mRNA  decay  factor 





suppressed  in  many  cancers,  altering  tumorigenic  phenotypes 
and patient prognosis. Cancer Res  2009, 69: 5168‐5176. 
103.  Kang  TH,Sancar  A.  Circadian  regulation  of  DNA  excision 
repair: implications for chrono‐chemotherapy. Cell Cycle  2009, 
8: 1665‐1667. 






P.  Circadian  control  of  the  NAD+  salvage  pathway  by  CLOCK‐
SIRT1. Science  2009, 324: 598‐599. 
107.  Hirayama  J,  Miyamura  N,  Uchida  Y,  Asaoka  Y,  Honda  R, 
Sawanobori K, Todo T, Yamamoto T, Sassone‐Corsi P, Nishina H. 
Common  light  signaling  pathways  controlling  DNA  repair  and 
circadian  clock  entrainment  in  zebrafish.  Cell  Cycle  2009,  8: 
2794‐2801. 
108. Vinogradova IA, Anisimov VN, Bukalev AV, Semenchenko 
AV,  Zabezhinski  MA.  Circadian  disruption  induced  by  light‐at‐
night  accelerates  aging  and  promotes  tumorigenesis  in  rats. 
Aging 2009, 1: 855‐865. 
109. Kondratov RV, Vykhovanets O, Kondratova AA, Antoch MP. 
Antioxidant  N‐acetyl‐L‐cysteine  ameliorates  symptoms  of 
premature aging associated with the deficiency of the circadian 
protein BMAL1. Aging 2009, 1: 979‐987. 




of  p53  in  mice  reveals  age‐associated  differences  in  tumor 
progression. PLoS One  2009, 4: e6654. 
112. Huang B, Vassilev LT. Reduced transcriptional activity in the 
p53  pathway  of  senescent  cells  revealed  by  the  MDM2 
antagonist nutlin‐3. Aging 2009, 1: 845‐854. 
113. Boily G, He XH, Pearce B, Jardine K, McBurney MW. SirT1‐

















www.impactaging.com                    121                                        AGING, March 2010, Vol.2 No.3